Antibody response to a fourth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series
The antibody response after 2 doses of an mRNA severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccine is excellent in the general population but less robust in …
coronavirus 2 (SARS-CoV-2) vaccine is excellent in the general population but less robust in …
A third dose of SARS‐CoV‐2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
…, JE Ruff, JN Blankson, AT Abedon… - American Journal of …, 2022 - Wiley Online Library
Vaccine‐induced SARS‐CoV‐2 antibody responses are attenuated in solid organ transplant
recipients (SOTRs) and breakthrough infections are more common. Additional SARS‐CoV‐…
recipients (SOTRs) and breakthrough infections are more common. Additional SARS‐CoV‐…
[HTML][HTML] A fourth dose of COVID-19 vaccine does not induce neutralization of the omicron variant among solid organ transplant recipients with suboptimal vaccine …
…, O Akinde, Y Eby, JE Ruff, AT Abedon… - …, 2022 - journals.lww.com
Background. Humoral responses to coronavirus disease 2019 (COVID-19) vaccines are
attenuated in solid organ transplant recipients (SOTRs), necessitating additional booster …
attenuated in solid organ transplant recipients (SOTRs), necessitating additional booster …
Improved antibody response after a fifth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series
AT Abedon, MS Teles, JL Alejo, JD Kim, J Mitchell… - …, 2022 - journals.lww.com
ATA, MST, JLA, JDK, JM, TPYC, RKA, AART, MLL, DSW, ABM, JMG-W., DLS, and WAW
participated in conception or design of the work; acquisition, analysis, or interpretation of data …
participated in conception or design of the work; acquisition, analysis, or interpretation of data …
[HTML][HTML] Heterologous versus homologous boosting elicits qualitatively distinct, BA. 5–cross-reactive T cells in transplant recipients
Background The SARS-CoV-2 Omicron BA. 5 subvariant escapes vaccination-induced
neutralizing antibodies because of mutations in the spike (S) protein. Solid organ transplant …
neutralizing antibodies because of mutations in the spike (S) protein. Solid organ transplant …
Antibody response to a fourth dose of SARS-CoV-2 vaccine in solid organ transplant recipients: an update
…, TPY Chiang, J Kim, A Chang, AT Abedon… - …, 2022 - journals.lww.com
Solid organ transplant recipients (SOTRs) have suboptimal antibody responses to 2-dose
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, with some …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, with some …
Omicron BA. 1 and BA. 2 neutralizing activity following pre-exposure prophylaxis with tixagevimab plus cilgavimab in vaccinated solid organ transplant recipients
Neutralizing antibody responses are attenuated in many solid organ transplant recipients (SOTRs)
despite SARS-CoV-2 vaccination. Pre-exposure prophylaxis (PrEP) with the …
despite SARS-CoV-2 vaccination. Pre-exposure prophylaxis (PrEP) with the …
Heterologous Ad. 26. COV2. S versus homologous BNT162b2/mRNA‐1273 as a third dose in solid organ transplant recipients seronegative after two‐dose mRNA …
…, JL Alejo, J Mitchell, JD Kim, AT Abedon… - American Journal of …, 2022 - Wiley Online Library
Heterologous vaccination (“mixing platforms”) for the third (D3) dose of SARS‐CoV‐2 vaccine
is a potential strategy to improve antibody responses in solid organ transplant recipients (…
is a potential strategy to improve antibody responses in solid organ transplant recipients (…
Effect of mycophenolate mofetil dosing on antibody response to SARS-CoV-2 vaccination in heart and lung transplant recipients
…, TPY Chiang, JL Alejo, A Chang, AT Abedon… - …, 2022 - journals.lww.com
Solid organ transplant recipients (SOTRs) demonstrate variable antibody responses after 2
doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine. 1 …
doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine. 1 …
[HTML][HTML] Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients
…, TPY Chiang, JL Alejo, I Sitaras, AT Abedon… - American Journal of …, 2023 - Elsevier
Neutralizing antibody (nAb) responses are attenuated in solid organ transplant recipients (SOTRs)
despite severe acute respiratory syndrome-coronavirus-2 vaccination. Preexposure …
despite severe acute respiratory syndrome-coronavirus-2 vaccination. Preexposure …
